YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Injured by Seroquel?
Seroquel, the popular schizophrenia drug, manufactured by AstraZeneca has been associated with a high incidence of diabetes. An abstract from a study on atypical antipsychotic medications reported that Seroquel users had a higher rate of diabetes than patients taking older medications. The findings from this study were detailed in a Wall Street Journal article on August 22, 2003. The article reported that the study was conducted on U.S. military veterans and demonstrated that Seroquel and other members of a new class of anti-psychotic drugs were linked to a higher risk of diabetes, but the risk of diabetes was greatest with Seroquel.Seroquel is known generically as (Quetiapine fumarate) and it is an oral medication used to manage the symptoms of schizophrenia including: delusions, thought disorder, hallucinations, social withdrawal, lack of energy, apathy, and reduced ability to express emotion. Seroquel affects a broad range of neurotransmitter receptors, including serotonin receptors.
Seroquel was approved by the FDA for marketing in 1997. Seroquel is an atypical antipsychotic agent in chemical class called dibenzothiazepine derivatives. Other atypical antipsychotic medications are Zyprexa, Geodon, Risperdal and Clozaril.
If you or a loved one took Seroquel and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
For more information please visit Parker & Waichman, LLP's Seroquel Site at www.seroqueldiabetes.com
SeroquelRSS Feed
Atypical Antipsychotic Drugs Used Inappropriately, Prescribed too Often, Critics Charge
Feb 18, 2008 | Parker Waichman Alonso LLP
Zyprexa, Seroquel, Abilify and other atypical antipsychotic drugs, meant to be used sparingly for severe mental illness like schizophrenia and bi-polar disorder, are being prescribed in increasing numbers to young children and the elderly. Doctors have helped to turn atypical antipsychotics like Zyprexa into blockbusters by prescribing them for more common conditions such as dementia and aggression. Some have accused drug makers of illegally promoting off-label uses as the reason...
Abuse of Risperdal, Seroquel, Other Antipsychotic Drugs in Nursing Homes Widespread
Dec 20, 2007 | Parker Waichman Alonso LLP
Use of antipsychotic drugs like Risperdal and Seroquel to control dementia patients has risen in recent years, despite the Food and Drug Administration's (FDA) "black box" warning labels that these drugs can increase the risk of death for elderly dementia sufferers. About 30% of nursing home residents are on antipsychotic drugs, according to the Centers for Medicare & Medicaid Services (CMS), most of them on newer, atypical antipsychotics. Federal law strongly...
FDA Again Warns About Suicidal Thoughts and Behavior Among Young Adults on Antidepressants
May 3, 2007 | NewsInferno.com
The U.S. Food and Drug Administration (FDA) today issued new warnings about suicidal thoughts and behavior related to young adults taking antidepressants, and they have asked drug makers to update their label warnings appropriately. The FDA uses the term “suicidality” to describe what they call suicidal thinking and behavior. The new “black-box” label warnings, the most strident type of warning, would reflect the increased risks of suicidality in young adults, ages 18...
FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
May 2, 2007 | www.fda.gov
The U.S. Food and Drug Administration (FDA) today proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months). The proposed labeling changes also include language stating that scientific data did not show this increased risk in adults older...
Study: Seniors Face Risks with All Antipsychotic Drugs
Feb 27, 2007 | NewsInferno.com
For the last couple of years, there have been a lot of questions raised about the cost, effectiveness, and safety of second-generation (or atypical) antipsychotic drugs such as Zyprexa, Seroquel, and Risperdal. However, a new Canadian study has found that older, conventional antipsychotic medications pose a similar risk of death to elderly patients perhaps an even greater risk than the atypical class. A new report published in the current issue of the Canadian Medical Association Journal...
Seroquel
Seroquel FDA Information
FDA Drug Information Facts
SEROQUEL (Quetiapine) FDA INFORMATION
The FDA issued several warnings concerning Seroquel related side effects. The links below will redirect you to these warnings on the FDA website.
Quick Facts
Seroquel Reference Guide
Generic Name
Quetiapine fumarate
Date Approved
September 26, 1997
Manufacturer
AstraZeneca
Status
Black box warning 4/12/2005
pproved Uses
Schizophrenia
Off Label Uses
Anxiety
OCD
Autism
Serious Side Effects
Diabetes
Hyperglycemia
Blood sugar disorders
Related Topics
Abilify
Clozaril
Geodon
Risperdal
Zyprexa
Diabetes
Defective Drugs
Diseases
Quetiapine fumarate
Date Approved
September 26, 1997
Manufacturer
AstraZeneca
Status
Black box warning 4/12/2005
pproved Uses
Schizophrenia
Off Label Uses
Anxiety
OCD
Autism
Serious Side Effects
Diabetes
Hyperglycemia
Blood sugar disorders
Related Topics
Abilify
Clozaril
Geodon
Risperdal
Zyprexa
Diabetes
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS